How Clinicians Prioritize Factors in Red Blood Cell Transfusions While Following Guidelines – AABB
Association for the Advancement of Blood and Biotherapies (AABB) shared a post on LinkedIn about a recent article by Aishwarya Katiki et al. published in Transfusion:
“AABB guidelines recommend a restrictive red blood cell transfusion strategy for most patient populations, while emphasizing the importance of considering individual signs, symptoms and clinical context when making transfusion decisions.
How do clinicians prioritize these factors in practice?
A survey of inpatient providers at UChicago Medicine explored which factors clinicians consider most important when deciding whether to transfuse.
Among 30 potential decision factors, seven were rated ‘very important’ by more than two-thirds of respondents, including five hemoglobin-related factors.”
José Antonio García Erce, Director of the Donation Center at Navarre Health Service (Osasunbidea), shared this post on LinkedIn:
“Are the criteria Restrictive?
No, they are obvious criteria!
It is Scientific and Ethical evidence!”
Title: Provider perceptions of indications for red blood cell transfusion
Authors: Aishwarya Katiki, Selwyn Rogers, Ryan Boudreau, David Meltzer, Micah Prochaska
Read the Full Article on Transfusion
Stay updated with Hemostasis Today.
-
Jun 11, 2026, 12:15Welcome to EHA 2026
-
Jun 11, 2026, 08:35Mohamed Reda: CBC Report – More Than Just Numbers
-
Jun 11, 2026, 07:59Uday Sankar Akash Vankayala: Key Findings on IBD-Associated VTE Phenotypes and Inpatient Burden
-
Jun 11, 2026, 07:41Zia Ullah: Hidden Cerebral Venous Sinus Thrombosis After Dengue Recovery
-
Jun 11, 2026, 07:24Aaron Rodriguez Calienes: RESISTANT Registry Provides Reassuring Safety Data for Acute Intracranial Stenting
-
Jun 11, 2026, 07:17Mbunya. S. Misiani: From the WFH Congress to Meaningful Change for Patients with Bleeding Disorders Worldwide
-
Jun 11, 2026, 07:06Bernard Slater Jr.: Hemophilia B Reminds You that No Matter How Strong You Are, You Are Still Human
-
Jun 11, 2026, 05:11Daniel I McIsaac: Less Blood Loss and No Excess VTE with Tranexamic Acid in High-Risk Surgery
-
Jun 11, 2026, 05:03Aymeric Couturier: Lessons from the TRACK Trial on Anticoagulation in Advanced CKD